Study finds non-disclosure of HIV serostatus common among India female sex workers

July 23, 2012

Researchers from Boston University School of Medicine (BUSM) in partnership with Indian researchers and HIV positive networks groups, have found that in India, non-disclosure of HIV serostatus to sex partners among both HIV-infected female sex workers (FSWs) and HIV-infected clients of FSWs is exceedingly common. These findings currently appear online in the journal AIDS and Behavior.

No previous studies in India specifically, and few internationally, have assessed FSWs' and male clients' disclosure of to sex partners. Disclosure of HIV serostatus to sex partners is viewed as a social and legal responsibility for HIV-infected individuals, particularly in the absence of . In many developing countries, high prevalence of non-disclosure, ranging from 17 to 86 percent, is considered to be an important factor promoting to sex partners. Disclosure to sex partners, on average, occurs less in developing countries than in the developed world (49 vs. 79 percent respectively).

Results were based on surveys conducted with HIV-infected FSW and infected male clients regarding HIV knowledge, awareness of sex partners' HIV serostatus, alcohol use, transactional sex involvement, post-HIV diagnosis and non-disclosure of HIV serostatus. Non-disclosure of one's serostatus to all sex partners was reported by almost three-fifths of females and two-fifths of males according to the researchers. Predictors of non-disclosure included lack of correct knowledge about HIV and no knowledge of sex partners' HIV serostatus. Among females, recent alcohol consumption also predicted non-disclosure. Among males, having ten (or more) paid sexual partners in the year following HIV diagnosis predicted non-disclosure.

"Disclosure is a complex decision for HIV- infected persons in India as in many other countries in the world and it may be influenced by a fear of losing clients or sex in paid or unpaid relationships," explained lead author Niranjan Saggurti, PhD, Co-Investigator of Alcohol Use and Sexual Risk in HIV-Infected Persons with Transactional Sex study at BUSM.

Saggurti believes that HIV prevention programs in India that seek to increase disclosure of HIV serostatus to sex partners may benefit from several factors including improving basic HIV knowledge, reducing , reducing the number of different sex partners and seeking knowledge about the serostatus of one's partner as a means to increase disclosure of HIV serostatus to sex partners.

Explore further: Researchers find alcohol plays no role in disclosing HIV status among Russians

Related Stories

Researchers find alcohol plays no role in disclosing HIV status among Russians

June 11, 2012
Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation ...

Higher HIV risk in black gay men linked to partner choice, risk perception

May 2, 2011
Young black men who have sex with men (MSM) get infected with HIV nearly five times more often than MSM from other races, even though they don't have more unprotected sex.

Study finds HIV-infected men at risk for spreading HIV despite taking HAART

March 27, 2012
Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men ...

Wednesday is national HIV testing day

June 26, 2012
(HealthDay) -- More than 1 million people in the United States are living with HIV, the virus that causes AIDS, but 20 percent of them don't know they're infected.

Recommended for you

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

HIV-AIDS: Following your gut

September 18, 2017
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have discovered a way to slow viral replication in the gastrointestinal tract of people infected by HIV-AIDS.

Study finds cutbacks in foreign aid for HIV treatment would cause great harm

August 30, 2017
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online ...

Cancer drug can reactivate HIV

August 24, 2017
People living with HIV must take a combination of three or more different drugs every day for the rest of their lives. Unfortunately, by following this strict treatment plan, they can suffer from side effects ranging from ...

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.